Search Within

Igor Odintsov

  1. "2022"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (1)
Groups
  1. Sloan Kettering Institute Postdocs (7)
  2. Department of Pathology and Laboratory Medicine (6)
  3. GSK Faculty (6)
  4. Human Oncology and Pathogenesis Program (6)
  5. Tow Center for Developmental Oncology (TCDO) (6)
  6. Pediatrics, Department of (3)

More Groups

People
  1. Marc Ladanyi (6)
  2. Romel Somwar (6)
  3. Elisa De Stanchina (5)
  4. Inna Khodos (5)
  5. Marissa Mattar (5)
  6. Jo Weng Allan Lui (3)

More People

Years
  1. 2022 (7)
Publications
  1. Cancer Discovery (1)
  2. Cancer Research (1)
  3. Cold Spring Harbor Molecular Case Studies (1)
  4. Disease Models & Mechanisms (1)
  5. Molecular Cancer Research (1)
  6. Neoplasma (1)

More Publications

Publishers
  1. American Association for Cancer Research (3)
  2. AEPress, s.r.o. (1)
  3. Cold Spring Harbor Laboratory Press (1)
  4. Company of Biologists (1)
  5. Wiley Periodicals, Inc (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting mTOR and MEK or ERK inhibits the growth of PDX models of NF1-deficient pediatric sarcoma
    Meeting Abstract

    Lu, Y. C.; Odintsov, I.; Khodos, I.; Mattar, M.; Glade Bender, J.; Wexler, L.; de Stanchina, E.; Ladanyi, M.; Somwar, R.
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Zenocutuzumab, a HER2XHER3 bispecific antibody, is effective therapy for tumors driven by NRG1 gene rearrangements
    Journal Article

    Schram, A. M.; Odintsov, I.; Espinosa-Cotton, M.; Khodos, I.; Sisso, W. J.; Mattar, M. S.; Lui, A. J. W.; Vojnic, M.; Shameem, S. H.; Chauhan, T.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • MYC promotes tyrosine kinase inhibitor resistance in ROS1-fusion-positive lung cancer
    Journal Article

    Iyer, S. R.; Odintsov, I.; Schoenfeld, A. J.; Siau, E.; Mattar, M. S.; de Stanchina, E.; Khodos, I.; Drilon, A.; Riely, G. J.; Ladanyi, M.; more...
    Molecular Cancer Research (2022)

    Fulltext@MSK | Save
  • CIC-mediated modulation of MAPK signaling opposes receptor tyrosine kinase inhibitor response in kinase-addicted sarcoma
    Journal Article

    Odintsov, I.; Ortiz, M. V.; Khodos, I.; Mattar, M. S.; Lui, A. J. W.; Kohsaka, S.; de Stanchina, E.; Glade Bender, J. L.; Ladanyi, M.; Somwar, R.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Determination of biological behavior of solitary fibrous tumors: Correlation of expression of Ki-67, TPX2 and TERT mRNA subunit level and NAB2-STAT6 fusion compared to morphological aspects of SFTs
    Journal Article

    Krsková, L.; Odintsov, I.; Fabián, O.; Hroudová, P.; Mrhalová, M.
    Neoplasma (2022)

    Fulltext@MSK | Save
  • Novel patient-derived models of desmoplastic small round cell tumor confirm a targetable dependency on ERBB signaling
    Journal Article

    Smith, R. S.; Odintsov, I.; Liu, Z.; Lui, A. J. W.; Hayashi, T.; Vojnic, M.; Suehara, Y.; Delasos, L.; Mattar, M. S.; Hmeljak, J.; more...
    Disease Models & Mechanisms (2022)

    Fulltext@MSK | Save
  • Functional impact and targetability of PI3KCA, GNAS, and PTEN mutations in a spindle cell rhabdomyosarcoma with MYOD1 L122R mutation
    Journal Article

    Choo, F.; Odinstov, I.; Nusser, K.; Nicholson, K. S.; Davis, L.; Corless, C. L.; Stork, L.; Somwar, R.; Ladanyi, M.; Davis, J. L.; more...
    Cold Spring Harbor Molecular Case Studies (2022)

    Fulltext@MSK | Save